BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36508281)

  • 1. Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.
    Martin de Frémont G; Vanjak A; Sbihi Z; Knapp S; Garzaro M; Chbihi M; Fournier B; Poirot J; Dossier A; Silvestrini MA; Villemonteix J; Meignin V; Galicier L; Bertinchamp R; Le Goff J; Salmona M; Flamarion E; Cassius C; Lebbé C; Ronchetti AM; Latour S; Oksenhendler E; Carcelain G; Boutboul D
    Blood Adv; 2023 May; 7(9):1682-1691. PubMed ID: 36508281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.
    Du MQ; Liu H; Diss TC; Ye H; Hamoudi RA; Dupin N; Meignin V; Oksenhendler E; Boshoff C; Isaacson PG
    Blood; 2001 Apr; 97(7):2130-6. PubMed ID: 11264181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
    Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
    J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
    Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.
    Zhou T; Yuan CM; Lurain K; Rous C; Weaver L; Raffeld M; Stetler-Stevenson M; Uldrick TS; Filie AC; Pittaluga S; Jaffe ES; Marshall V; Moore K; Whitby D; Ramaswami R; Yarchoan R; Wang HW
    Br J Haematol; 2023 Feb; 200(4):462-475. PubMed ID: 36264007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.
    Polizzotto MN; Uldrick TS; Hu D; Yarchoan R
    Front Microbiol; 2012; 3():73. PubMed ID: 22403576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
    Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
    Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
    Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
    Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Venkataraman G; Uldrick TS; Aleman K; O'Mahony D; Karcher DS; Steinberg SM; Raffeld MA; Marshall V; Whitby D; Little RF; Yarchoan R; Pittaluga S; Maric I
    Am J Clin Pathol; 2013 May; 139(5):651-61. PubMed ID: 23596117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
    Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
    Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
    Uldrick TS; Polizzotto MN; Aleman K; O'Mahony D; Wyvill KM; Wang V; Marshall V; Pittaluga S; Steinberg SM; Tosato G; Whitby D; Little RF; Yarchoan R
    Blood; 2011 Jun; 117(26):6977-86. PubMed ID: 21487108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case.
    Kim B; Jeon YK; Kim CW
    J Korean Med Sci; 2009 Oct; 24(5):970-4. PubMed ID: 19795003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human herpesvirus 8+ polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients.
    Oksenhendler E; Boutboul D; Beldjord K; Meignin V; de Labarthe A; Fieschi C; Dossier A; Agbalika F; Parravicini C; Tosato G; Gérard L; Galicier L
    Eur J Haematol; 2013 Dec; 91(6):497-503. PubMed ID: 23992152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deconstructing the liquid architecture of human herpesvirus 8 diseases.
    Polizzotto MN
    Br J Haematol; 2023 Feb; 200(4):401-403. PubMed ID: 36397674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
    Carbone A; De Paoli P; Gloghini A; Vaccher E
    Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Uldrick TS; Polizzotto MN; Yarchoan R
    Curr Opin Oncol; 2012 Sep; 24(5):495-505. PubMed ID: 22729151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.
    Uldrick TS; Polizzotto MN; Aleman K; Wyvill KM; Marshall V; Whitby D; Wang V; Pittaluga S; O'Mahony D; Steinberg SM; Little RF; Yarchoan R
    Blood; 2014 Dec; 124(24):3544-52. PubMed ID: 25331113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The morphologic variants of KSHV/HHV 8-associated lymphoproliferations].
    Loddenkemper C; Longerich T; Schneider T; Anagnostopoulos I; Foss HD; Schirmacher P; Stein H
    Pathologe; 2007 Feb; 28(1):46-9. PubMed ID: 17160657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.
    Ray A; Marshall V; Uldrick T; Leighty R; Labo N; Wyvill K; Aleman K; Polizzotto MN; Little RF; Yarchoan R; Whitby D
    J Infect Dis; 2012 Jun; 205(11):1665-76. PubMed ID: 22448005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi sarcoma herpesvirus-associated cancers and related diseases.
    Goncalves PH; Ziegelbauer J; Uldrick TS; Yarchoan R
    Curr Opin HIV AIDS; 2017 Jan; 12(1):47-56. PubMed ID: 27662501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.